Mallinckrodt completed its merger with Questcor on 8/14/2014
Sentiment: Strong Buy
"But most giant pharmas will want the whole thing for all indications. Nevertheless, they could secure additional partnerships."
Are you suggesting that ARNA could partner a single drug with different pharmas for different indications?
He couldn't make a large unplanned buy, if he was working on any sort of significant deal.